Duran Ayse Ocak, Anil Cuneyd, Gursoy Alptekin, Nar Aslı, Inanc Mevlude, Bozkurt Oktay, Tutuncu Neslihan Bascil
Department of Medical Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Department of Endocrinology and Metabolism, Faculty of Medicine, Baskent University, Ankara, Turkey.
Arq Bras Endocrinol Metabol. 2014 Nov;58(8):824-7. doi: 10.1590/0004-2730000003418. Epub 2014 Nov 1.
Thyroid volume and the prevalence of thyroid nodules are higher in patients with insulin resistance. A relationship between thyroid volume and glucose metabolism disorders (GMD) has not as yet been clarified. The present retrospective study aimed to investigate the association between GMD and thyroid volume.
We investigated the data of 2,630 patients who were evaluated for thyroid biopsy in our hospital. The study population included 602 patients with GMD, 554 patients with diabetes mellitus (DM) and 1,474 patients with normal glucose metabolism as a control group. We obtained the levels of serum thyroid stimulating hormone (TSH) and the thyroid volumes of those patients retrospectively.
The median ages for the control group, GMD group and DM group were 55 (15-91) years, 60 (27-97) years, and 65 (27-91) years respectively and there was a statistically significant difference between the groups with regard to age and gender (p<0.001). Levels of TSH were similar in all groups. The median total thyroid volumes for patients with DM and GMD were significantly higher than that of the control group [22.5 (3-202) mL, 20.2 (4-190) mL, and 19.2 (3-168) mL respectively, p≤0.001 for all parameters]. Also the median total thyroid volume for patients with DM was significantly higher than that of the GMD group (p<0.001). According to the correlation analysis, thyroid volume was significantly correlated with age (r=0.92, p<0.001) and TSH (r=0.435, p<0.001). Age, gender, TSH levels, GMD and DM diagnosis were independently correlated with thyroid volume.
The thyroid gland is one of the target tissues of metabolic disorders. We reported a positive correlation between GMD/type 2 DM and thyroid volume. Further controlled, prospective, randomized studies on this subject are required to gain more information.
胰岛素抵抗患者的甲状腺体积和甲状腺结节患病率较高。甲状腺体积与糖代谢紊乱(GMD)之间的关系尚未阐明。本回顾性研究旨在探讨GMD与甲状腺体积之间的关联。
我们调查了在我院接受甲状腺活检评估的2630例患者的数据。研究人群包括602例GMD患者、554例糖尿病(DM)患者和1474例糖代谢正常的患者作为对照组。我们回顾性获取了这些患者的血清促甲状腺激素(TSH)水平和甲状腺体积。
对照组、GMD组和DM组的中位年龄分别为55(15 - 91)岁、60(27 - 97)岁和65(27 - 91)岁,各组在年龄和性别方面存在统计学显著差异(p<0.001)。所有组的TSH水平相似。DM和GMD患者的中位总甲状腺体积显著高于对照组[分别为22.5(3 - 202)mL、20.2(4 - 190)mL和19.2(3 - 168)mL,所有参数p≤0.001]。此外,DM患者的中位总甲状腺体积显著高于GMD组(p<0.001)。根据相关性分析,甲状腺体积与年龄(r = 0.92,p<0.001)和TSH(r = 0.435,p<0.001)显著相关。年龄、性别、TSH水平、GMD和DM诊断与甲状腺体积独立相关。
甲状腺是代谢紊乱的靶组织之一。我们报告了GMD/2型糖尿病与甲状腺体积之间存在正相关。需要对此主题进行进一步的对照、前瞻性、随机研究以获取更多信息。